We are a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases.
$14.00 - $16.00
October 25, 2019
MORGAN STANLEY & CO. LLC,COWEN AND COMPANY, LLC
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Cabaletta Bio IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277